RIP Watson, The Creepy Robot Voice From IBM’s Commercials

International Business Machines is seeking a potential sale of its IBM Watson Health business, as the tech behemoth’s new CEO moves to become more competitive in cloud computing.

IBM is looking at alternative prospects for those semi-creepy Watson robot-voice commercials which could include a sale to a private-equity firm or a merger with a blank-check company. The entire unit, which utilizes AI to assist hospitals, insurers and drug makers in overseeing their data, has roughly $1 billion in annual revenue and isn’t currently profitable.

Its brands include Merge Healthcare, which analyzes mammograms and MRIs; Phytel, which assists with patient communications; and Truven Health Analytics, which analyzes complex healthcare data. It isn’t clear how much the business might fetch in a sale. Heck, there may not even be one in the works yet.

IBM, with a market value of $108 billion, has been left in the dust as cloud-computing competitors Microsoft [$MSFT] and Amazon [$AMZN] climb to valuations more than 10 times greater. The company has said it’s focused on boosting its hybrid-cloud operations while exiting some unrelated businesses.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s